We have barely begun to tap into the pharmaceutical potential of the most diverse animals of all.
Good models have been developed to ensure benefit sharing in the biodiversity business. But major challenges prevent developing countries from translating this into social justice.
The next cancer breakthrough could be found in international waters – but who's in charge of the high seas?
How scientists and corporations are plundering the developing world for new substances.